SLC5A2 and type 2 diabetes mellitus: Inhibition of SGLT-2 blocks the reabsorption of glomerularly filtered glucose (and sodium) in the ensuing proximal S1/S2 segment, a mechanism that has been exploited to reduce hyperglycemia in patients with type 2 diabetes mellitus [1].